Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cavitation Technologies (CVAT) Shares Outstanding (Diluted Average) (2016 - 2025)

Cavitation Technologies' Shares Outstanding (Diluted Average) history spans 10 years, with the latest figure at $301.2 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) rose 5.94% to $301.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $301.2 million, a 5.94% increase, with the full-year FY2025 number at $286.0 million, up 0.6% from a year prior.
  • Shares Outstanding (Diluted Average) hit $301.2 million in Q4 2025 for Cavitation Technologies, up from $289.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for CVAT hit a ceiling of $301.2 million in Q4 2025 and a floor of $285005.1 in Q1 2025.
  • Historically, Shares Outstanding (Diluted Average) has averaged $252.6 million across 5 years, with a median of $279.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): surged 36.36% in 2022 and later tumbled 99.9% in 2025.
  • Tracing CVAT's Shares Outstanding (Diluted Average) over 5 years: stood at $225.8 million in 2021, then rose by 22.54% to $276.7 million in 2022, then grew by 2.74% to $284.3 million in 2023, then changed by 0.0% to $284.3 million in 2024, then rose by 5.94% to $301.2 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for CVAT at $301.2 million in Q4 2025, $289.2 million in Q3 2025, and $286.0 million in Q2 2025.